Latest News
As city faces shortfall, cuts loom for schools, health and other departments : Local News : Memphis Commercial Appeal
Commercial Appeal (Memphis, Tenn.), The | 1 hour 1 minute ago
With a controversial year behind it, the City Council is preparing for what promises to be another challenging year in 2009.... (more)
ESL tutors help foreign students attain fluency in everyday English : Relationships : Memphis Commercial Appeal
Commercial Appeal (Memphis, Tenn.), The | 1 hour 1 minute ago
Memphis Literacy Council volunteers Dr. Jose Morey and Ke Qi began a recent lesson by asking one student to introduce herself to the class.... (more)
Teva settles MassHealth fraud lawsuit
Boston Globe, The | 1 hour 6 minutes ago
NEW YORK - Teva Pharmaceutical Industries Ltd., the world's biggest maker of generic drugs, paid $7 million to settle a suit claiming it charged illegally inflated prices to Massachusetts' Medicaid program.... (more)
Endo to buy Indevus Pharmaceuticals
Boston Globe, The | 1 hour 6 minutes ago
NEW YORK - Endo Pharmaceutical Holdings Inc. said yesterday that it will buy Lexington, Mass.-based Indevus Pharmaceuticals Inc. for $370 million upfront, or $4.50 per share, acquiring Indevus's urology and hormone drug candidates in the process.... (more)
Scientist at Work - Rob Holman - So Much to Learn About the Oceans From Sand - Biography - NYTimes.com
New York Times, The | 1 hour 35 minutes ago
CORVALLIS, Ore. As a young geophysicist in the 1980s, Rob Holman attended a conference in San Francisco that included a field trip to a beach. Dr. Holman, who grew up inland, in Ottawa, stared at the ocean, assessing the strengths and vectors of the waves and currents. But when he looked around, everyone else was studying the sand. He realized, he recalled, that sand is not the same everywhere. So he started collecting it. I collected a few samples and put them in jars, he said. Then...... (more)
CRIME REPORT: Cars pounded by rocks hurled from bridge over Paul Barret Parkway : Local News : Memphis Commercial Appeal
Commercial Appeal (Memphis, Tenn.), The | 3 hours 35 minutes ago
Three vehicles, including a patrol car, have been pounded by rock or concrete chunks hurled from the Donnell Road bridge over Paul Barret Parkway in North Shelby County.... (more)
Endo to buy Indevus for $370 million upfront
Boston Globe, The | 3 hours 39 minutes ago
NEW YORK—Endo Pharmaceutical Holdings Inc. said Monday it will buy Indevus Pharmaceuticals Inc. for $370 million upfront, or $4.50 per share, acquiring Invedus' urology and hormone drug candidates in the process.... (more)
Investor's Business Daily: Biotech Firm Sticks To Its Work While Drug Giant Roche Circles
Investor's Business Daily | 4 hours 27 minutes ago
Posted 1/5/2009 Last summer, Genentech (DNA) rejected Swiss drug maker Roche Holding's $43.7 billion offer to buy the company. The $89-a-share bid was too low, the biotech giant's board said, but it kept the door open for a higher bid.... (more)
Biogen shares fall on JP Morgan downgrade - Forbes.com
Forbes | 6 hours 14 minutes ago
Shares of Biogen Idec Inc. fell Monday after JP Morgan cut its rating on the stock, saying the multiple sclerosis drug Tysabri could continue facing challenges in 2009 while the company lacks any catalysts to drive new revenue.... (more)
Indevus Pharmaceuticals Announces Definitive Merger Agreement With Endo Pharmaceuticals - Press Releases: PR Newswire: Utilities - SunHerald.com
Sun Herald (Biloxi-Gulfport, Miss.), The | 6 hours 57 minutes ago
"For many reasons, we are very pleased to bring this transaction to the shareholders and other stakeholders of the Company," said Glenn L. Cooper, M.D., chairman and chief executive officer of Indevus. "For our shareholders, the deal not only captures a significant premium in the up-front portion of the consideration, but our investors will also maintain a significant interest in the downstream value creation from NEBIDO and the octreotide implant.... (more)
ConMed Struck Down By Dollar Gain - Forbes.com
Forbes | 9 hours 6 minutes ago
ConMed was already wounded last year by penny-pinching hospital administrators, but what really scarred the maker of minimally invasive surgical equipment was the unexpected revival of the dollar in the fourth quarter.... (more)
Sector Snap: Medical technology shares slide - Forbes.com
Forbes | 9 hours 6 minutes ago
Shares of medical technology companies mostly traded lower Monday after an Oppenheimer analyst predicted hospitals will cut their spending by 15 percent to 25 percent in 2009, and reduced his estimates on a half dozen companies.... (more)
Chain Drug Review::Top Stories
Chain Drug Review | 12 hours 14 minutes ago
WALNUT CREEK, Calif. — These are heady days for Warren Bryant, until last fall chairman, president and chief executive officer of Longs Drug Stores.... (more)
57 Stories | 
RSS Feed
Sign up for ANA SmartBrief
Companies in the news
- Amgen Inc.
- Caraco Pharmaceutical
- Catholic Healthcare West
- Fresenius Medical Care
- Genentech Inc
- Gilead Sciences Inc
- Logistics
- Management Group Inc.
- Ranbaxy Laboratories Ltd.
- Rite Aid Corp
- Sandoz Inc
- Shelby County
- St. Jude Children Research Hospital
- Sutter Health
- Teleflex Inc